Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma

Addition of induction chemotherapy (IC) to concurrent chemoradiotherapy (CC) is an encouraging first-line treatment strategy for patients with locoregionally advanced nasopharyngeal carcinoma (NPC). We evaluated the clinical efficacy and toxicity of addition of gemcitabine plus cisplatin (GP) IC to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Fangzheng, Wang, Quanquan, Sun, Chuner, Jiang, Lei, Wang, Fengqin, Yan, Zhimin, Ye, Tongxin, Liu, Min, Xu, Peng, Wu, Haitao, Jiang, Aizawa, Rihito, Sakamoto, Masoto, Yuezhen, Wang, Zhenfu, Fu
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5722524/
https://ncbi.nlm.nih.gov/pubmed/29228572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18245
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars